Profile
Roger G.
H.
Downer is a Director of Westaim Corp.
and has been a Director of NUCRYST Pharmaceuticals Corp.
since December 2005.
Previously, he was President, Vice Chancellor and President-Emeritus of the University of Limerick from 1998 to 2006 and President of the Asian Institute of Technology from 1996 to 1998.
Dr. Downer received a BS and an MS from Queen's University of Belfast and a PhD from the University of Western Ontario.
Former positions of Roger G. H. Downer
| Companies | Position | End |
|---|---|---|
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Director/Board Member | 08/02/2010 |
| University of Limerick | Director/Board Member | 31/12/2005 |
| Asian Institute of Technology | President | 31/12/1997 |
| THE WESTAIM CORPORATION | Director/Board Member | - |
Training of Roger G. H. Downer
| Queen's University of Belfast | Graduate Degree |
| University of Western Ontario | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| THE WESTAIM CORPORATION | Finance |
| Private companies | 1 |
|---|---|
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Health Technology |
- Stock Market
- Insiders
- Roger G. H. Downer
